APA

Etienne G., Dulucq S., Nicolini F., Morisset S., Fort M., Schmitt A., Etienne M., Hayette S., Lippert E., Bureau C., Tigaud I., Adiko D., Marit G., Reiffers J. & Mahon F. (20150413). Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy. : Haematologica.

Chicago

Etienne Gabriel, Dulucq Stéphanie, Nicolini Franck-Emmanuel, Morisset Stéphane, Fort Marie-Pierre, Schmitt Anna, Etienne Madeleine, Hayette Sandrine, Lippert Eric, Bureau Caroline, Tigaud Isabelle, Adiko Didier, Marit Gérald, Reiffers Josy and Mahon François-Xavier. 20150413. Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy. : Haematologica.

Harvard

Etienne G., Dulucq S., Nicolini F., Morisset S., Fort M., Schmitt A., Etienne M., Hayette S., Lippert E., Bureau C., Tigaud I., Adiko D., Marit G., Reiffers J. and Mahon F. (20150413). Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy. : Haematologica.

MLA

Etienne Gabriel, Dulucq Stéphanie, Nicolini Franck-Emmanuel, Morisset Stéphane, Fort Marie-Pierre, Schmitt Anna, Etienne Madeleine, Hayette Sandrine, Lippert Eric, Bureau Caroline, Tigaud Isabelle, Adiko Didier, Marit Gérald, Reiffers Josy and Mahon François-Xavier. Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy. : Haematologica. 20150413.